| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |